BackPharmigene Overview

Pharmigene Profit Margin

Latest profit margin for Pharmigene: -37.89% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

Quarterly Profit Margin

-30.00%
↑ 41.44% YoY

As of Jun 2026

Annual Profit Margin (TTM)

-37.89%
↑ 30.38% YoY

Trailing 12 months ending Jun 2026

Average Profit Margin (Comparison Companies)

Loading

Profit Margin History

Loading

Profit Margin Comparison

Loading

Annual Profit Margin Growth Rate (%)

Loading

Pharmigene (7595.TWO) FAQ

The latest profit margin for 7595.TWO is -37.89% as of June 2026. That compares with -54.42% in the prior-year period — up 30.4% year over year. That is below the sector sector average of 13.4%. Investors often review this figure alongside Pharmigene's historical trend and sector peers before judging valuation or financial health.

Over the past year, 7595.TWO's profit margin moved from -54.42% to -37.89% — a 30.4% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Pharmigene's valuation or profitability profile.

Against its sector companies, 7595.TWO currently prints -37.89% for profit margin, while the sector average sits near 13.4%. That is roughly 382.7% below the sector mean. Large gaps often invite a closer look at Pharmigene's growth, margins, and balance sheet.

Profit Margin shows how effectively Pharmigene converts resources into returns. At -37.89%, 7595.TWO may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -54.42% in the prior-year period — up 30.4% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting 7595.TWO's profit margin (-37.89%), review year-over-year change from -54.42%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.